Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer. Bardia A, Hurvitz SA, Tolaney SM, Loirat D, et al. N Engl J Med 2021;384:1529-1541.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bardia A, Hurvitz SA, Tolaney SM, Loirat D, et al. Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer. N Engl J Med 2021;384:1529-1541.
PMID: 33882206